Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2002

Primary Completion Date

September 30, 2003

Study Completion Date

February 29, 2004

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

panitumumab

Trial Locations (2)

19111

Fox Chase Cancer Center, Philadelphia

90095-1738

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00054574 - Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter